Sökning: "hazard rate"
Visar resultat 36 - 40 av 176 avhandlingar innehållade orden hazard rate.
36. Epidemiologic studies on rheumatic muscle inflammation, myositis
Sammanfattning : Observational study designs are often used in medical research. Swedish national registers have successfully been used as data sources for such observational studies in other rheumatic diseases. LÄS MER
37. Myocardial infarction - Risk stratification and evaluation of therapies
Sammanfattning : Background. Myocardial infarction (MI) remains the leading cause of death worldwide, despite several advances in acute coronary care during the last decades. This thesis assessed different risk stratification tools and evaluated interventional and pharmacological treatment strategies in high-risk patients with MI. Methods. LÄS MER
38. Prevention of Mother to Child Transmission of HIV in Africa : Operational Research to Reduce Post-natal Transmission and Infant Mortality
Sammanfattning : This thesis assesses the effectiveness of the National Prevention of Mother to Child Transmission of HIV (PMTCT) programme in 3 sites in South Africa, and the quality of infant feeding counselling across four countries, Botswana, Kenya, Malawi and Uganda . Implementation and outcome of PMTCT services were very different across the 3 sites. LÄS MER
39. Product support and spare parts considering system reliability and operating environment
Sammanfattning : The required spare parts planning for a system/machine is an integral part of the product support strategy. The number of required spare parts can be effectively estimated on the basis of the product reliability characteristics. LÄS MER
40. Diffuse large B-cell lymphoma : population-based studies of relapse and cardiac complications
Sammanfattning : Diffuse large B-cell lymphoma (DLBCL) is an aggressive life-threatening disease, but it is often possible to cure with immunochemotherapy. Not responding to primary treatment or having a relapse is associated with poor prognosis. However, it has not been well described how large the proportion of patients with relapsed/refractory disease is. LÄS MER